The WAVES Study uses ultrasound therapy to treat vulvovaginal atrophy (VVA) in women who have failed or are not candidates for hormonal therapy. It involves a 3-month, at-home treatment program designed to improve quality of life and day-to-day mobility.
Qualified Participants Must Be:
- A woman between the ages of 21 and 66
- Experiencing vulvovaginal atrophy that significantly impacts daily life
- Not qualified for, or have failed, hormonal therapy for VVA
Participants Will Receive:
- Study-related care at no cost
- Compensation for time and travel
Medical insurance is not required for study participation. To learn more or to enroll, please contact Sophie Maraghi at 202-293-1000 or smaraghi@intimmedicie.com